Company Overview
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. The company operates in two segments, Skin care, health and wellness; and Green energy. It offers two series of programs that consist of various services and products under the ATP Zeta Health Program and E.A.T.S. names. The company also provides ionized and high bioavailability nutrients to enhance absorption at the cellular level, energized mineral concentrate, soy protein isolate powder, LIVO5, and solutions for sustainability and energy savings; and promotes environmental stewardship. In addition, it promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. Further, the company provides renewable energy products, technical solutions, installations, and maintenance services, as well as digital wellness platform. Agape ATP Corporation was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.
Why Investors Should Care
Revenue has grown at a 15.3% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.28.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.52M (+15.2% YoY); net profit $-2.28M.
- Trailing 12 Months Year-on-year growth — revenue -93.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 15.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 15.33% |
| 1 Year: | -93.40% |
Stock Price Performance
| 1 Year: | -96.43% |
| 6 Months: | +14.36% |
| 3 Months: | -24.26% |
| 1 Month: | -12.17% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)41.72 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 15.3% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 96.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ATPC Agape ATP Corporation | 2.31 | -2.41 | $2.31M | 0.00% | -14.45% | -5.48% | 15.33% | - |
| 2 | WMT Walmart Inc. SPXR3K | 107.14 | 38.82 | $850.02B | 0.93% | 16.83% | 22.31% | 3.82% | 3.24% |
| 3 | COST Costco Wholesale Corporation NDXSPXR3K | 910.18 | 45.88 | $403.65B | 0.65% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPXR3K | 88.36 | 26.53 | $380.17B | 2.41% | 16.47% | 42.05% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPXR3K | 145.58 | 21.99 | $338.39B | 2.95% | 22.49% | 30.29% | 0.52% | 1.59% |
| 6 | PM Philip Morris International Inc. SPXR3K | 184.73 | 25.37 | $287.92B | 3.09% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPXR3K | 138.45 | 18.15 | $189.12B | 4.43% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | BUD Anheuser-Busch InBev SA/NV | 79.73 | 17.18 | $139.30B | 1.69% | 8.49% | 11.39% | 0.88% | 4.63% |
| 9 | BTI British American Tobacco p.l.c. | 55.15 | 14.18 | $118.73B | 5.98% | 12.44% | 13.42% | -2.53% | 5.21% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2017 | Dec 2017 | Mar 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 415.37K | - | 464.30K | - | 236.74K | - | 1.51M | 1.41M | 301.78K | 303.79K | 201.28K | 408.96K | 396.71K | 663.89K | 380.77K | 303.94K | 355.31K | 318.64K | 313.04K | 331.29K | 289.04K | 465.50K | 370.59K | 273.66K |
| Gross Profit | 45.89K | - | - | 36.94K | 28.99K | 44.12K | -700 | 26.35K | - | 1.05M | 1.23M | 224.19K | 268.16K | 164.62K | 335.53K | 287.32K | 506.14K | 252.41K | 196.00K | 234.73K | 203.42K | 193.56K | 184.19K | 156.29K | 208.94K | 239.10K | 159.41K |
| Operating Income | 45.89K | - | - | - | - | 15.89K | -59.94K | -76.83K | -159.52K | 46.19K | 410.65K | -342.51K | -409.00K | -365.00K | -272.23K | -306.18K | -193.31K | -453.88K | -359.53K | -317.08K | -723.54K | -453.58K | -548.11K | -720.40K | -636.96K | -601.32K | -677.37K |
| Net Income | -54.61K | -123.98K | -24.68K | -135.87K | -6.58K | 71.22K | -448.41K | -98.06K | -231.75K | 87.24K | 415.04K | -333.65K | -642.23K | -571.26K | -299.10K | -414.90K | -240.71K | -425.84K | -374.69K | -327.03K | -709.71K | -442.70K | -509.63K | -712.92K | -617.08K | -586.83K | -340.91K |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.01 | 0.00 | -0.01 | 0.00 | -0.09 | -0.18 | -0.12 | -0.13 | -3.63 | -0.01 | -0.01 | -0.33 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2017 | Jun 2018 | Jun 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 487.00K | 1.55M | 1.29M | 3.43M | 1.02M | 1.86M | 1.43M | 1.32M | 1.52M |
| Gross Profit | - | 45.60K | 109.35K | 89.30K | 2.68M | 719.63K | 1.19M | 936.57K | 759.15K | 838.27K |
| Operating Income | - | -234.09K | -131.17K | -314.59K | -158.13K | -1.86M | -1.53M | -2.15M | -2.57M | -3.26M |
| Net Income | -75.36K | -130.27K | -519.64K | -716.13K | 354.77K | -2.52M | -1.69M | -2.10M | -2.47M | -2.28M |
| Diluted EPS | - | - | - | - | - | - | -0.02 | -0.55 | -31.74 | -2.85 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2016 | Jun 2017 | Jun 2018 | Dec 2018 | Jun 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 2.31M | 5.13M | 5.20M | 4.65M | 4.34M | 7.21M | 4.72M | 2.79M | 5.74M | 3.24M | 24.59M |
| Total Equity | -24.99K | 2.30M | 5.10M | 4.96M | 4.58M | 4.25M | 5.92M | 3.31M | 1.54M | 4.37M | 1.93M | 22.46M |
| Cash & Equivalents | 10 | 2.31M | 3.53M | 3.45M | 2.86M | 2.74M | 3.52M | 2.60M | 1.44M | 4.83M | 2.04M | 140.07K |
| Total Liabilities | - | 8.10K | 29.75K | 241.85K | 71.40K | 83.99K | 1.29M | 1.41M | 1.23M | 1.36M | 1.31M | 2.17M |
| Current Liabilities | - | 8.10K | 29.75K | 241.85K | 71.40K | 83.99K | 1.04M | 1.31M | 1.23M | 1.07M | 1.12M | 2.05M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2017 | Jun 2018 | Jun 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -100.26K | -347.98K | -667.06K | -704.42K | -557.95K | -845.84K | -811.68K | -2.00M | -2.73M | -2.41M |
| Investing Cash Flow | - | -1.36M | -2.50K | -1.50K | 1.28M | -3.96K | -32.12K | -17.25K | -50.05K | -23.00M |
| Financing Cash Flow | 2.41M | 2.93M | -5.32K | -4.57K | -22.09K | -19.06K | -234.47K | 5.40M | -11.86K | 23.50M |
| Capital Expenditure | - | - | - | - | -4.73K | -3.96K | - | - | - | - |
| Free Cash Flow | - | - | - | - | -562.68K | -849.80K | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Jun 2017 | Jun 2018 | Jun 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | 9.4% | 7.1% | 6.9% | 77.9% | 70.8% | 64.1% | 65.4% | 57.4% | 55.0% |
| Operating Margin % | - | -48.1% | -8.5% | -24.4% | -4.6% | -182.8% | -82.6% | -150.0% | -194.5% | -213.7% |
| Net Margin % | - | -26.8% | -33.6% | -55.5% | 10.3% | -248.2% | -90.9% | -146.9% | -186.8% | -149.6% |
| ROE % | -3.3% | -2.6% | -11.3% | -16.8% | 6.0% | -76.2% | -109.4% | -48.1% | -127.8% | -10.2% |
| ROCE % | - | -4.6% | -2.9% | -7.4% | -2.6% | -54.5% | -98.1% | -45.9% | -121.4% | -14.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | HRT Financial LP | 5.88% | 58.85K | $131.23K |
| 2 | Jane Street Group, LLC | 4.59% | 45.93K | $102.43K |
| 3 | UBS Group AG | - | 8 | $17 |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ATPC
Agape ATP (ATPC) Stock Rallies Over 42% After Hours: Here's What Is Going On - Benzinga
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQa3ZkTGEzX2FGZGRUZm4zdl9TeW9IWFAyUnNwc2ExX2oybnNQY1RPQ2JKM3dwTUxOeWNmTDd6MFNIZURXSWZnRFhzZDlhWE04akhTNWY2WmxOdXhIT0pDNnBaemJnQ2xQb3RoNEtBQklvdW5uZnQ1RHNpWHd3TjdUSEU0V2FOSllpdXFjRF…
Jane Street’s 5% Agape ATP Corp (ATPC) stake detailed in SEC ownership filing - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNNFNJOGw1X1dJckVXc3pIV2RLSmR3bzRRVm1mUk5qSHQ1OWhVQlZtWld3UUJnSzRKUHl4R3ZLUUNsUEE1QlNZcVAwczVHQlV1U1A0VTg4UFY5ZW9iZ29kV2R3UGJPRWg1VkJ0WmdsaHZUSFctSjlHOHJVeHN6VWdNS1U5TlduOE5RNDY5Z0…
ATPC Stock Just Witnessed A Relentless Rally Of 160% In Three Sessions – What’s Driving Investor Enthusiasm? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPV0R0ZkRCRzE1M1c2dUFEOXQwODYzRW8zcUQxXzNTLUVia1doNVFjU3p0bFZIaVVtR0E5WWQ5anN3OU41Z3ZuNGxiSnY5NkVVLTUyUXkzY2Z4dGowTlNmX0lNSU9DS3pvamJ0TDhNV2JsS3F5cXFPbVhCeWU3NEZRTHZMRU9IN2FqbW5pbX…
Agape ATP (ATPC) surges 129.1% as micro-cap momentum spikes, with no single fresh headline apparent - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNdURNeHY2WGx5OXM3dHlzZFd4VlNwLXgtYkwxbXJBYmMya3hHT2pJdDRaVTk4NEx6U1JaTUZCYjlqRFBpWG5SWlNYcVZkNk1acGtpcGxleXVZRXUzWXY2SFVkOEIwLVAzblFGUUVRR1BYTXlnd3BIeWh6RHVYdGszX2Mtdm9ZSWxFS1pOZm…
ATPC Stock Climbs As Traders Focus On Balance Sheet Strength - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE8yZjdyclBDX2c4Z1BkVEJTV0xoclFwbUtyY2tuR1BVUWNVVmhSVm9OT2Z1TWs4N0NnMXEtVmVUWGluamZCaTlxMlJWVlpVM2JzS3RsTmxhNzRNeHpBRXJ6cTE1SzJfTV9CZW1BbWtrTDJuMGlkSE5NOHY2NHFfQ2M?oc=5" target="_bla…
ATPC - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTFBuTUtPR2lqWTZWTUtxajZsQnpiak5oS2I2UC14cjJPTmk1V1ZsUU00amNtd2dCbzMzNFJBbHhIU003LW5HVFE?oc=5" target="_blank">ATPC</a> <font color="#6f6f6f">Finviz</font>…
ATPC — Frequently Asked Questions
What is the current share price of Agape ATP Corporation (ATPC)?
As of 2026-09-19 21:16 PDT, Agape ATP Corporation (ATPC) trades at $2.31 on NasdaqCM. Its 52-week range is $1.83 to $69.25.
What is the market capitalisation of ATPC?
Agape ATP Corporation (ATPC) has a market capitalisation of $2.31M on NasdaqCM.
What is the P/E ratio of ATPC?
ATPC trades at a trailing price-to-earnings (P/E) ratio of -2.41. The industry average P/E is 18.56. Its price-to-book (P/B) ratio is 0.11.
What is the return on equity (ROE) of ATPC?
ATPC has a return on equity (ROE) of -5.48%. Its return on capital employed (ROCE) is -14.45%.
Is ATPC a good stock to buy?
This page provides a data-driven analysis of Agape ATP Corporation (ATPC), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.